Transcriptional control of natural killer cell differentiation and function

  • Alfonso Martín-Fontecha
  • Graham M. Lord
  • Hugh J. M. Brady
Multi-author review

Abstract

Gene expression can be modulated depending on physiological and developmental requirements. A multitude of regulatory genes, which are organized in interdependent networks, guide development and eventually generate specific phenotypes. Transcription factors (TF) are a key element in the regulatory cascade controlling cell fate and effector functions. In this review, we discuss recent data on the diversity of TF that determine natural killer (NK) cell fate and NK cell function.

Keywords

Transcription factor NK cell differentiation Migration Effector function 

Notes

Acknowledgments

The authors acknowledge the support of the Swiss National Science Foundation (31-109832 to AMF) and the Medical Research Council-UK (G0802068 to G.M.L. and A.M.F., and G0901737 to H.J.B.). The authors also acknowledge financial support from the Department of Health via the National Institute for Health research (NIHR) comprehensive Biomedical Research Centre award to Guy’s & St Thomas’ NHS Foundation Trust in partnership with King’s College London and King’s College Hospital NHS Foundation Trust.

Conflict of interest

The authors have no conflicting financial interests.

References

  1. 1.
    Russell L, Garrett-Sinha LA (2010) Transcription factor Ets-1 in cytokine and chemokine gene regulation. Cytokine 51:217–226PubMedCrossRefGoogle Scholar
  2. 2.
    Barton K et al (1998) The Ets-1 transcription factor is required for the development of natural killer cells in mice. Immunity 9:555–563PubMedCrossRefGoogle Scholar
  3. 3.
    Medina KL et al (2004) Assembling a gene regulatory network for specification of the B cell fate. Dev Cell 7:607–617PubMedCrossRefGoogle Scholar
  4. 4.
    Colucci F et al (2001) Differential requirement for the transcription factor PU.1 in the generation of natural killer cells versus B and T cells. Blood 97:2625–2632PubMedCrossRefGoogle Scholar
  5. 5.
    Lacorazza HD et al (2002) The ETS protein MEF plays a critical role in perforin gene expression and the development of natural killer and NK-T cells. Immunity 17:437–449PubMedCrossRefGoogle Scholar
  6. 6.
    Szabo SJ et al (2002) Distinct effects of T-bet in TH1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells. Science 295:338–342PubMedCrossRefGoogle Scholar
  7. 7.
    Townsend MJ et al (2004) T-bet regulates the terminal maturation and homeostasis of NK and Valpha14i NKT cells. Immunity 20:477–494PubMedCrossRefGoogle Scholar
  8. 8.
    Hosoya T, Maillard I, Engel JD (2010) From the cradle to the grave: activities of GATA-3 throughout T-cell development and differentiation. Immunol Rev 238:110–125PubMedCrossRefGoogle Scholar
  9. 9.
    Samson SI et al (2003) GATA-3 promotes maturation, IFN-gamma production, and liver-specific homing of NK cells. Immunity 19:701–711PubMedCrossRefGoogle Scholar
  10. 10.
    Vosshenrich CA et al (2006) A thymic pathway of mouse natural killer cell development characterized by expression of GATA-3 and CD127. Nat Immunol 7:1217–1224PubMedCrossRefGoogle Scholar
  11. 11.
    Lohoff M et al (2000) Deficiency in the transcription factor interferon regulatory factor (IRF)-2 leads to severely compromised development of natural killer and T helper type 1 cells. J Exp Med 192:325–336PubMedCrossRefGoogle Scholar
  12. 12.
    Taki S, Nakajima S, Ichikawa E, Saito T, Hida S (2005) IFN regulatory factor-2 deficiency revealed a novel checkpoint critical for the generation of peripheral NK cells. J Immunol 174:6005–6012PubMedGoogle Scholar
  13. 13.
    Quong MW, Romanow WJ, Murre C (2002) E protein function in lymphocyte development. Annu Rev Immunol 20:301–322PubMedCrossRefGoogle Scholar
  14. 14.
    Yokota Y et al (1999) Development of peripheral lymphoid organs and natural killer cells depends on the helix–loop–helix inhibitor Id2. Nature 397:702–706PubMedCrossRefGoogle Scholar
  15. 15.
    Ikawa T, Fujimoto S, Kawamoto H, Katsura Y, Yokota Y (2001) Commitment to natural killer cells requires the helix–loop–helix inhibitor Id2. Proc Natl Acad Sci USA 98:5164–5169PubMedCrossRefGoogle Scholar
  16. 16.
    Boos MD, Yokota Y, Eberl G, Kee BL (2007) Mature natural killer cell and lymphoid tissue-inducing cell development requires Id2-mediated suppression of E protein activity. J Exp Med 204:1119–1130PubMedCrossRefGoogle Scholar
  17. 17.
    Ramirez K, Kee BL (2010) Multiple hats for natural killers. Curr Opin Immunol 22:193–198PubMedCrossRefGoogle Scholar
  18. 18.
    Schotte R et al (2010) Synergy between IL-15 and Id2 promotes the expansion of human NK progenitor cells, which can be counteracted by the E protein HEB required to drive T cell development. J Immunol 184:6670–6679PubMedCrossRefGoogle Scholar
  19. 19.
    Gascoyne DM et al (2009) The basic leucine zipper transcription factor E4BP4 is essential for natural killer cell development. Nat Immunol 10:1118–1124PubMedCrossRefGoogle Scholar
  20. 20.
    Liu P et al (2003) Bcl11a is essential for normal lymphoid development. Nat Immunol 4:525–532PubMedCrossRefGoogle Scholar
  21. 21.
    Li P et al (2010) Reprogramming of T cells to natural killer-like cells upon Bcl11b deletion. Science 329:85–89PubMedCrossRefGoogle Scholar
  22. 22.
    Di Santo JP (2010) Immunology. A guardian of T cell fate. Science 329:44–45PubMedCrossRefGoogle Scholar
  23. 23.
    Wilkinson B et al (2002) TOX: an HMG box protein implicated in the regulation of thymocyte selection. Nat Immunol 3:272–280PubMedCrossRefGoogle Scholar
  24. 24.
    Aliahmad P, de la Torre B, Kaye J (2010) Shared dependence on the DNA-binding factor TOX for the development of lymphoid tissue-inducer cell and NK cell lineages. Nat Immunol 11:945–952PubMedCrossRefGoogle Scholar
  25. 25.
    Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S (2008) Functions of natural killer cells. Nat Immunol 9:503–510PubMedCrossRefGoogle Scholar
  26. 26.
    Colonna M (2009) Interleukin-22-producing natural killer cells and lymphoid tissue inducer-like cells in mucosal immunity. Immunity 31:15–23PubMedCrossRefGoogle Scholar
  27. 27.
    Szabo SJ et al (2000) A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100:655–669PubMedCrossRefGoogle Scholar
  28. 28.
    Glimcher LH, Townsend MJ, Sullivan BM, Lord GM (2004) Recent developments in the transcriptional regulation of cytolytic effector cells. Nat Rev Immunol 4:900–911PubMedCrossRefGoogle Scholar
  29. 29.
    Lord GM et al (2005) T-bet is required for optimal proinflammatory CD4+T-cell trafficking. Blood 106:3432–3439PubMedCrossRefGoogle Scholar
  30. 30.
    Werneck MB, Lugo-Villarino G, Hwang ES, Cantor H, Glimcher LH (2008) T-bet plays a key role in NK-mediated control of melanoma metastatic disease. J Immunol 180:8004–8010PubMedGoogle Scholar
  31. 31.
    Rot A, von Andrian UH (2004) Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. Annu Rev Immunol 22:891–928PubMedCrossRefGoogle Scholar
  32. 32.
    Martin-Fontecha A et al (2004) Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming. Nat Immunol 5:1260–1265PubMedCrossRefGoogle Scholar
  33. 33.
    Wendel M, Galani IE, Suri-Payer E, Cerwenka A (2008) Natural killer cell accumulation in tumors is dependent on IFN-gamma and CXCR3 ligands. Cancer Res 68:8437–8445PubMedCrossRefGoogle Scholar
  34. 34.
    Garrett WS et al (2007) Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system. Cell 131:33–45PubMedCrossRefGoogle Scholar
  35. 35.
    Garrett WS et al (2009) Colitis-associated colorectal cancer driven by T-bet deficiency in dendritic cells. Cancer Cell 16:208–219PubMedCrossRefGoogle Scholar
  36. 36.
    Jenner RG et al (2009) The transcription factors T-bet and GATA-3 control alternative pathways of T-cell differentiation through a shared set of target genes. Proc Natl Acad Sci USA 106:17876–17881PubMedCrossRefGoogle Scholar
  37. 37.
    Cyster JG (2005) Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs. Annu Rev Immunol 23:127–159PubMedCrossRefGoogle Scholar
  38. 38.
    Chiba K et al (1998) FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. I. FTY720 selectively decreases the number of circulating mature lymphocytes by acceleration of lymphocyte homing. J Immunol 160:5037–5044PubMedGoogle Scholar
  39. 39.
    Mandala S et al (2002) Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists. Science 296:346–349PubMedCrossRefGoogle Scholar
  40. 40.
    Walzer T et al (2007) Natural killer cell trafficking in vivo requires a dedicated sphingosine 1-phosphate receptor. Nat Immunol 8:1337–1344PubMedCrossRefGoogle Scholar
  41. 41.
    Jenne CN et al (2009) T-bet-dependent S1P5 expression in NK cells promotes egress from lymph nodes and bone marrow. J Exp Med 206:2469–2481PubMedCrossRefGoogle Scholar
  42. 42.
    Trotta R et al (2008) TGF-beta utilizes SMAD3 to inhibit CD16-mediated IFN-gamma production and antibody-dependent cellular cytotoxicity in human NK cells. J Immunol 181:3784–3792PubMedGoogle Scholar
  43. 43.
    Gross O et al (2008) Multiple ITAM-coupled NK-cell receptors engage the Bcl10/Malt1 complex via Carma1 for NF-kappaB and MAPK activation to selectively control cytokine production. Blood 112:2421–2428PubMedCrossRefGoogle Scholar
  44. 44.
    Tassi I et al (2008) NK cell-activating receptors require PKC-theta for sustained signaling, transcriptional activation, and IFN-gamma secretion. Blood 112:4109–4116PubMedCrossRefGoogle Scholar
  45. 45.
    Page KM, Chaudhary D, Goldman SJ, Kasaian MT (2008) Natural killer cells from protein kinase C theta-/- mice stimulated with interleukin-12 are deficient in production of interferon-gamma. J Leukoc Biol 83:1267–1276PubMedCrossRefGoogle Scholar
  46. 46.
    Kaisho T et al (1999) Impairment of natural killer cytotoxic activity and interferon gamma production in CCAAT/enhancer binding protein gamma-deficient mice. J Exp Med 190:1573–1582PubMedCrossRefGoogle Scholar
  47. 47.
    Cooper C, Henderson A, Artandi S, Avitahl N, Calame K (1995) Ig/EBP (C/EBP gamma) is a transdominant negative inhibitor of C/EBP family transcriptional activators. Nucleic Acids Res 23:4371–4377PubMedCrossRefGoogle Scholar
  48. 48.
    Davydov IV, Bohmann D, Krammer PH, Li-Weber M (1995) Cloning of the cDNA encoding human C/EBP gamma, a protein binding to the PRE-I enhancer element of the human interleukin-4 promoter. Gene 161:271–275PubMedCrossRefGoogle Scholar
  49. 49.
    Ito A et al (2001) Inhibitory effect on natural killer activity of microphthalmia transcription factor encoded by the mutant mi allele of mice. Blood 97:2075–2083PubMedCrossRefGoogle Scholar
  50. 50.
    Lohoff M et al (1997) Interferon regulatory factor-1 is required for a T helper 1 immune response in vivo. Immunity 6:681–689PubMedCrossRefGoogle Scholar
  51. 51.
    Duncan GS, Mittrucker HW, Kagi D, Matsuyama T, Mak TW (1996) The transcription factor interferon regulatory factor-1 is essential for natural killer cell function in vivo. J Exp Med 184:2043–2048PubMedCrossRefGoogle Scholar
  52. 52.
    Taki S et al (1997) Multistage regulation of Th1-type immune responses by the transcription factor IRF-1. Immunity 6:673–679PubMedCrossRefGoogle Scholar
  53. 53.
    Zheng W, Flavell RA (1997) The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 89:587–596PubMedCrossRefGoogle Scholar
  54. 54.
    Wahl SM, Wen J, Moutsopoulos NM (2006) The kiss of death: interrupted by NK-cell close encounters of another kind. Trends Immunol 27:161–164PubMedCrossRefGoogle Scholar
  55. 55.
    Macian F (2005) NFAT proteins: key regulators of T-cell development and function. Nat Rev Immunol 5:472–484PubMedCrossRefGoogle Scholar
  56. 56.
    Nguyen KB et al (2002) Coordinated and distinct roles for IFN-alpha beta, IL-12, and IL-15 regulation of NK cell responses to viral infection. J Immunol 169:4279–4287PubMedGoogle Scholar
  57. 57.
    Nguyen KB et al (2000) Interferon alpha/beta-mediated inhibition and promotion of interferon gamma: STAT1 resolves a paradox. Nat Immunol 1:70–76PubMedGoogle Scholar
  58. 58.
    Reefman E et al (2010) Cytokine secretion is distinct from secretion of cytotoxic granules in NK cells. J Immunol 184:4852–4862PubMedCrossRefGoogle Scholar

Copyright information

© Springer Basel AG 2011

Authors and Affiliations

  • Alfonso Martín-Fontecha
    • 1
  • Graham M. Lord
    • 1
  • Hugh J. M. Brady
    • 2
  1. 1.Medical Research Council (MRC) Centre for Transplantation, Guy’s Hospital King’s College LondonLondonUK
  2. 2.Section of Immunity and Infection, Cell and Molecular Biology Division, Department of Life Sciences, Immunology and InfectionImperial College LondonLondonUK

Personalised recommendations